Medical Labs Sue US Government Over Medicare Fees

The American Clinical Laboratory Association claims that scheduled reimbursements for tests are too low and could put small companies out of business.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, U.S. NAVY PHOTO BY MASS COMMUNICATION SPECIALIST 2ND CLASS CHELSEA A. BLOMThe American Clinical Laboratory Association (ACLA) has filed a lawsuit against the US government for what it considers to be unfair payments for tests covered by Medicare, the federal health insurance program for seniors. At stake is about $670 million in payments for testing services that the ACLA says the government is shortchanging companies, according to Reuters.

The complaint stems from a 2014 law that aimed to ensure Medicare was paying about the same as private insurers for medical tests. To determine a fair price, the government surveyed clinical testing companies for their rates, but the ACLA claims that it reviewed only a small fraction of the market—namely, large firms that turn around a high volume and charge comparatively less than smaller ones.

According to Reuters, the lawsuit claims that less than 1 percent of the medical testing market had submitted fee rates to the Department of Health and Human Services, which runs Medicare.

“It is reckless and damaging to Medicare beneficiaries for the [Health and Human Services] Secretary to implement a payment system based on a specious data collection process that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies